“…From lung tissue, for example, fibroblasts have been shown to be heterogeneous with regard to morphology (15,34), proliferative capacity (6,20,24,34,48), surface marker (Thy-1, MHC class II, CD4) expression (11,34), type and amount of collagen production (11,16), intracellular metabolic pathways (15), and cytokine production (15). In addition, fibroblasts from nonpulmonary tissues have been shown to be heterogeneous with regard to proliferation (2,22), size and shape (18,19), presence of lipid droplets (29), collagen synthesis (13,16,21,36,40,49,51), expression of growth factors (16), response to and synthesis of PGE 2 , and expression of C1q surface receptors, among others. One wonders about heterogeneity in some of the other key functions of fibroblasts, such as capacity for transition to other cell types (i.e., myofibroblast and/or SM cell), migration, protease expression, and propensity to apoptosis.…”